Lindis biotech presents encouraging data from bladder cancer trial by John Pinching | Nov 14, 2022 | News | 0 Data revealed that 100% of patients achieved a complete remission with no recurrence Read More
NICE recommends wireless device for overactive bladder by Anna Smith | Feb 14, 2020 | News | 0 The device has potential to save the NHS around £6,200 per patient assuming a 15-year life span. Read More
Merck’s Bavencio hits targets in bladder cancer interim analysis by Anna Smith | Jan 7, 2020 | News | 0 Last year the drug disappointed in the Phase III JAVELIN Gastric 100 study, but has pulled itself back with new urothelial carcinoma data. Read More
Tecentriq combo proves effective in bladder cancer by Anna Smith | Oct 2, 2019 | News | 0 The drug improved progression-free survival to 8.2 months from 6.3 months. Read More